Discover our new M*Detect product for digital PCR !
MDetect kits from METHYS Dx are based on proprietary methylation signatures and are compatible with commercially available digital PCR instruments. MDetect kits are used to analyze circulating tumor DNA from patients with advanced cancers (stages III–IV). Thanks to the use of digital PCR, results can be obtained within a single day.
Our tests are based on liquid biopsies, and target the analysis of certain types of biomarkers, present in biological fluids, such as blood. METHYS Dx develops panels of methylation markers, in order to characterize circulating tumor DNA (ctDNA) within liquid biopsies. The tests developped by METHYS Dx will thus be used to establish prognosis, monitor tumor evolution, and allow the early detection of relapses.
The tests developped by METHYS Dx target different cancer types, amongst the most frequent. These tests are based on a novel detection technology, and present an efficient and less-costly alternative to NGS tests. METHYS Dx tests can also be used for quality control of results obtained using other technologies (NGS or digital PCR for example).
Innovation
Precision & Reliability
Passion
METHYS Dx services activities and R&D program are based for a large part on research carried out within the MEPPOT and SPM laboratories. You may browse through the original publications of their work in this section.
🎭✨Valerie Taly takes the stage! Valerie Taly pitched at the Théâtre des Variétés in Paris for the Trophées de la Healtech Edition 2026, and what a memorable evening it was for the METHYS Dx team! 🤩First of all, a huge thank you to France Biotech for this wonderful evening, and kudos to Nicolas Rossignol for […]
> Know more
🚀METHYS Dx signs exclusive License Agreement with CNRS Innovation for disruptive detection technology!! 🤝We are pleased to announce that METHYS Dx has signed an exclusive license agreement with CNRS Innovation covering three patent families on an ultra-sensitive and disruptive detection technology. 🔬 This technology primarily originates from collaborative work between CNRS and Université de Tokyo, […]
> Know more